27.02.2013 Views

conspectus of researchon copper metabolism and requirements

conspectus of researchon copper metabolism and requirements

conspectus of researchon copper metabolism and requirements

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

COPPER METABOLISM AND REQUIREMENTS OF MAN 2035<br />

to solutions used for total patenterai nutri<br />

tion for prolonged periods (177, 711, 712,<br />

864). To these, <strong>of</strong> course, must be added<br />

the amount contributed by the casein hydrolysate<br />

or other protein components <strong>of</strong><br />

the infúsate. These vary considerably in<br />

their <strong>copper</strong> content. Somewhat contrary<br />

to these estimates is the report <strong>of</strong> Mc-<br />

Kenzie et al. (511) that in seven adult<br />

patients in a surgical intensive care unit a<br />

parenteral infúsate providing 0.09 to 0.8<br />

mg <strong>of</strong> <strong>copper</strong> resulted in a negative bal<br />

ance in all cases.<br />

Some useful information has also come<br />

from studies concerned with <strong>copper</strong> levels<br />

required to compensate for states <strong>of</strong> cop<br />

per deficiency resulting from an inade<br />

quacy in parenteral fluids. An excellent<br />

example is the study <strong>of</strong> Vilter et al. (808).<br />

In a 56-year old woman with malabsorption<br />

<strong>and</strong> severe systemic sclerosis <strong>of</strong> the<br />

intestine, maintained on total parenteral<br />

nutrition for 2.5 months, they observed<br />

typical manifestations <strong>of</strong> <strong>copper</strong> deficiency.<br />

For 4 months she had shown leucopenia,<br />

neutropenia <strong>and</strong> a hypocellular bone mar<br />

row, considered typical manifestations <strong>of</strong><br />

<strong>copper</strong> deficiency. Serum <strong>copper</strong> was very<br />

low (0.02 fig/ml ) <strong>and</strong> serum ceruloplasmin<br />

was not demonstrable. Intravenous admin<br />

istration <strong>of</strong> 1 mg/day for 7 days resulted in<br />

an excellent response, still evident 90 days<br />

later. Hence 7 mg <strong>of</strong> <strong>copper</strong> sulfate dis<br />

tributed over 90 days, equivalent to 0.077<br />

mg <strong>of</strong> <strong>copper</strong> per day, represented more<br />

than minimal <strong>requirements</strong> for this woman.<br />

Here again, a reasonable estimate <strong>of</strong> cop<br />

per acquired via the protein hydrolysate<br />

component might increase the uptake to<br />

approximately 0.1 mg/day.<br />

Dunlap et al. ( 177) describe a state <strong>of</strong><br />

<strong>copper</strong> deficiency in a 45-year old woman<br />

<strong>and</strong> a 12-year old girl receiving long-term<br />

parenteral nutrition following extensive<br />

bowel surgery. The older subject, after<br />

almost total dependence on parenteral<br />

feeding for about 17 months, developed<br />

anemia <strong>and</strong> neutropenia which responded<br />

rapidly to oral <strong>copper</strong> sulfate (5 mg CuSO4<br />

or 1.25 mg elemental <strong>copper</strong>) daily, which<br />

was continued for 45 days. With discon<br />

tinuation <strong>of</strong> <strong>copper</strong>-therapy for about one<br />

month, deficiency symptoms were again<br />

apparent <strong>and</strong> responded well to 1.6 mg<br />

<strong>copper</strong> sulfate (0.4 mg/day) given intra<br />

venously. After 2 weeks the daily dose was<br />

increased to 1 mg <strong>copper</strong> for 5 weeks. Sub<br />

sequently, she was on a parenteral dose <strong>of</strong><br />

0.4 mg <strong>copper</strong> daily <strong>and</strong> showed no evi<br />

dence <strong>of</strong> recurrence <strong>of</strong> hématologieabnor<br />

malities. The younger subject, who had<br />

been dependent entirely on parenteral<br />

nutrition for only 4 months, showed neutro<br />

penia (but no anemia) which also re<br />

sponded to oral <strong>copper</strong> therapy. The fact<br />

that oral <strong>copper</strong> was effectively absorbed<br />

by both subjects, in whom the duodenum<br />

had been anastomosed to the transverse<br />

colon, provides additional evidence that<br />

the stomach <strong>and</strong> duodenum play a major<br />

role in the absorption <strong>of</strong> <strong>copper</strong> in man.<br />

Of special interest are the data derived<br />

from studies on the older subject clearly<br />

indicating that a daily parenteral intake <strong>of</strong><br />

0.4 mg <strong>of</strong> elemental <strong>copper</strong> effected a<br />

rapid recovery from a deficiency state.<br />

The observations <strong>of</strong> Vilter et al. ( 808 ), also<br />

carried out on a single adult woman, are in<br />

close agreement with those <strong>of</strong> Dunlap et<br />

al. (177).<br />

One conclusion that may be justified<br />

from these two studies is that the "uncom<br />

plicated" minimal intravenous requirement<br />

<strong>of</strong> <strong>copper</strong> for man may well be less than<br />

0.4 mg per day. By "uncomplicated" is<br />

meant under situations where ingested<br />

<strong>copper</strong> is not being subjected to the in<br />

fluence <strong>of</strong> many other components <strong>of</strong> the<br />

diet (other trace elements which compete<br />

for binding sites, dietary fiber, phytates,<br />

etc.) or may otherwise interfere with maxi<br />

mal absorption. Assuming a 40 to 60% ab<br />

sorption <strong>of</strong> oral <strong>copper</strong>, this would repre<br />

sent an oral intake <strong>of</strong> approximately 1 mg/<br />

day.<br />

Two recent examples <strong>of</strong> the inadequacy<br />

<strong>of</strong> parenteral infusâtescommonly in use in<br />

hospitals can be cited. Weekly serum cop<br />

per determinations on eight adult patients<br />

receiving total parenteral nutrition for 3 to<br />

13 weeks revealed a progressive decrease<br />

<strong>of</strong> serum <strong>copper</strong> <strong>and</strong> three patients showed<br />

severe hypocupremia. The infúsate had no<br />

detectable <strong>copper</strong>. All responded rapidly to<br />

oral <strong>copper</strong> feeding (217). Another study<br />

(726) describes a progressive decline in<br />

plasma <strong>copper</strong> (<strong>and</strong> also zinc) in 13 sub<br />

jects with active gastrointestinal disorders<br />

Downloaded from<br />

jn.nutrition.org<br />

by guest on February 27, 2013

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!